Clinical Trial Update: Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, PK and PD of SCH 900518 in adults with chronic hepatitis C (genotype 1) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SCH 900518

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED